- Published at
- by thestreet.com
positive
positive
Miravo Healthcare™ Announces Receipt Of Health Canada Notice Of Compliance For The Pediatric Use Of Blexten®
- Blexten Label Expanded to Include Ages as Young as 4 Years Old - - Includes Approval of 2.5mg/mL Oral Solution and 10mg orodispersible (Quick Melt) Tablet